本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kazia Therapeutics Limited

10.36
-0.8000-7.17%
盤後10.560.2000+1.93%19:30 EDT
成交量:49.58萬
成交額:519.90萬
市值:1.45億
市盈率:-1.52
高:11.11
開:11.11
低:10.21
收:11.16
52周最高:17.40
52周最低:4.86
股本:1,400.69萬
流通股本:1,165.62萬
量比:1.96
換手率:4.25%
股息:- -
股息率:- -
每股收益(TTM):-6.8190
每股收益(LYR):-12.3849
淨資產收益率:-106.90%
總資產收益率:-25.70%
市淨率:4.38
市盈率(LYR):-0.84

資料載入中...

2026/08/19

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/27

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/26

SEC問詢函

Form CORRESP - Correspondence
2025/12/23

SEC問詢函

Form CORRESP - Correspondence
2025/12/23

SEC問詢函

Form CORRESP - Correspondence
2025/12/19

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/11/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/09/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/02/03

SEC問詢函

Form CORRESP - Correspondence
2025/01/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/15

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/03

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

SEC問詢函

Form CORRESP - Correspondence